ConductScience.org, home

Paper · 40293448

Radiolabeling lipoproteins to study and manage disease.

Pérez-Medina C and 4 others. Eur J Nucl Med Mol Imaging, 2025. Cited by 2 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Radiolabeling lipoproteins to study and manage disease. Papers, record 40293448. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40293448

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Radiolabeling lipoproteins to study and manage disease.
PubMed
Journal
Eur J Nucl Med Mol Imaging
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
2
iCite
Revised in PubMed
2026-08-22
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Pérez-Medina CCarlos
2Fisher EAEdward A
3Fayad ZAZahi A
4Mulder WJMWillem J M
5Teunissen AJPAbraham J Phttps://orcid.org/0000-0002-0401-8262

Source PubMed

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
LipoproteinsMajor topic
Isotope LabelingMajor topic
RadiopharmaceuticalsMajor topic
Humans
Animals

Source PubMed

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
P01 AI168258NIAID NIH HHSUnited StatesP01AI168258PubMed and NIHNIH RePORTER
P01 HL131478NHLBI NIH HHSUnited StatesP01HL131478PubMed and NIHNIH RePORTER
1P01AI168258-01Division of Intramural Research, National Institute of Allergy and Infectious DiseasesP01AI168258PubMed and NIHNIH RePORTER
2P01HL131478-06A1NHLBI Division of Intramural ResearchP01HL131478PubMed and NIHNIH RePORTER

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References211

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
11,770,304In vivo metabolism of apolipoprotein A-I on high density lipoprotein particles LpA-I and LpA-I,A-II.J Lipid Res1991https://conductscience.org/library/papers/1770304PubMed
227,319,780Nanoreporter PET predicts the efficacy of anti-cancer nanotherapy.Nat Commun2016https://conductscience.org/library/papers/27319780PubMed
38,060,378The metabolic fate of apolipoprotein A-I-containing lipoproteins internalized into HepG2 cells: resecreted lipoproteins as a potent inducer for cholesterol efflux.Atherosclerosis1994https://conductscience.org/library/papers/8060378PubMed
416,024,913HDLs in apoA-I transgenic Abca1 knockout mice are remodeled normally in plasma but are hypercatabolized by the kidney.J Lipid Res2005https://conductscience.org/library/papers/16024913PubMed
534,503,276The Race for Hydroxamate-Based Zirconium-89 Chelators.Cancers (Basel)2021https://conductscience.org/library/papers/34503276PubMed
612,005,032Comparison of two methods for radioiodination on the oxidizability properties of low density lipoprotein.J Physiol Biochem2001https://conductscience.org/library/papers/12005032PubMed
722,414,908Cholesterol efflux assay.J Vis Exp2012https://conductscience.org/library/papers/22414908PubMed
88,485,122Fenofibrate and LDL metabolic heterogeneity in hypercholesterolemia.Arterioscler Thromb1993https://conductscience.org/library/papers/8485122PubMed
97,033,286Sites of tissue binding and uptake in vivo of bacterial lipopolysaccharide-high density lipoprotein complexes: studies in the rat and squirrel monkey.J Clin Invest1981https://conductscience.org/library/papers/7033286PubMed
107,316,186Iodination of proteins, glycoproteins, and peptides using a solid-phase oxidizing agent, 1,3,4,6-tetrachloro-3 alpha,6 alpha-diphenyl glycoluril (Iodogen).Anal Biochem1981https://conductscience.org/library/papers/7316186PubMed

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn PapersSource
42,064,614Targeted PET Imaging of Atherosclerosis via Low-Density Lipoprotein Click Chemistry with Nanoparticles.Chem Biomed Imaging2026https://conductscience.org/library/papers/42064614PubMed
40,937,965Dendrimers Improve Apolipoprotein Nanoparticle mRNA Delivery to Immune Cells.Adv Mater2026https://conductscience.org/library/papers/40937965PubMed

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40293448

GET https://conductscience.org/api/papers/v1/40293448/references?page=2